Form 4: BDX Director Eckert Acquires 1,098 Shares via RSU Grant
Insider Transaction Report
Becton, Dickinson and Company Director R. Andrew Eckert acquired 1,098 shares of common stock through a restricted stock unit grant.
Summary
- R. Andrew Eckert, a Director of Becton, Dickinson and Company (BDX), acquired 1,098 shares of common stock.
- The acquisition occurred on January 27, 2026, and represents a grant of restricted stock units (RSUs).
- The RSUs were awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
- Following this transaction, Eckert beneficially owns a total of 10,423 shares of BDX common stock.
- The total beneficial ownership includes units acquired through dividend reinvestment since the last report.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged acquisition.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting a planned equity compensation grant to a director, which aligns management incentives with shareholder interests.
Positives
- Director R. Andrew Eckert increased his direct beneficial ownership in Becton, Dickinson and Company by 1,098 shares.
- The acquisition was through a restricted stock unit grant, which aligns director incentives with shareholder value.
- The transaction was made under a Rule 10b5-1(c) plan, indicating a pre-planned and transparent acquisition.
Industry Context
StockSavvy.ai notes that insider acquisitions, even through RSU grants, can signal management's confidence in the company's long-term prospects, a common practice in the medical technology and device industry.
Comparison to Industry Standards
- Insider ownership and equity compensation plans are standard practices across the healthcare and medical device industry, including peers like Medtronic (MDT) and Johnson & Johnson (JNJ), to align executive and director interests with shareholder value.
- The grant of RSUs at a $0 price is typical for compensation awards and is consistent with industry practices for director remuneration.
Related Party Transactions
- Grant of 1,098 restricted stock units to Director R. Andrew Eckert under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan, with a transaction price of $0 per unit.
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholder value through equity ownership.
Key Dates
| Date | Description |
|---|---|
| 01/27/2026 | Date of acquisition of 1,098 shares of common stock via restricted stock unit grant. |
| 01/29/2026 | Date the Form 4 was signed by power of attorney. |
Recommendation
holdThis Form 4 reports a routine restricted stock unit grant to a director, which is a standard component of executive compensation. While it increases insider ownership, it does not represent an open market purchase or a significant new development that would warrant a change in investment recommendation. The transaction is expected and aligns director incentives, supporting a 'hold' recommendation based solely on this filing.
Keywords
Becton Dickinson, BDX, Form 4, Insider Trading, Restricted Stock Units, RSU, Director Stock Acquisition, Equity Compensation, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.